Prostate Cancer
Testing home-based exercise strategies in underserved minority cancer patients undergoing chemotherapy (THRIVE) trial: a study protocol.
October 14, 2024
Nivolumab in patients with metastatic castration-resistant prostate cancer with and without DNA repair defects.
October 14, 2024
Radiotherapy and theranostics: a Lancet Oncology Commission.
October 14, 2024
Post-Treatment surveillance intensity and overall survival in prostate cancer survivors (AFT-30).
October 14, 2024
Detection of Germline Variants in Patients with Localized and Metastatic Prostate Cancer through Guideline-Based Testing.
October 14, 2024
Methylation-based immune deconvolution in prostate cancer patients before and after radical prostatectomy.
October 14, 2024
Aiming High: Prostate-specific Membrane Antigen Expression in Treatment-naïve Prostate Cancer.
October 14, 2024
Clarity enters a Clinical Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
October 11, 2024
Proteomic and phosphoproteomic landscape of localized prostate cancer unveils distinct molecular subtypes and insights into precision therapeutics.
October 11, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.
October 11, 2024